KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) EBT Margin (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed EBT Margin for 13 consecutive years, with 74.76% as the latest value for Q4 2025.

  • Quarterly EBT Margin fell 503.0% to 74.76% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 68.93% through Dec 2025, down 872.0% year-over-year, with the annual reading at 68.93% for FY2025, 872.0% down from the prior year.
  • EBT Margin hit 74.76% in Q4 2025 for ClearPoint Neuro, down from 66.39% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 54.08% in Q1 2024 to a low of 119.85% in Q2 2023.
  • Historically, EBT Margin has averaged 78.55% across 5 years, with a median of 74.25% in 2022.
  • Biggest five-year swings in EBT Margin: tumbled -4651bps in 2021 and later skyrocketed 6394bps in 2024.
  • Year by year, EBT Margin stood at 96.82% in 2021, then grew by 11bps to 86.37% in 2022, then rose by 20bps to 69.1% in 2023, then dropped by -1bps to 69.72% in 2024, then decreased by -7bps to 74.76% in 2025.
  • Business Quant data shows EBT Margin for CLPT at 74.76% in Q4 2025, 66.39% in Q3 2025, and 63.07% in Q2 2025.